ATE171448T1 - Thiazolidin-2,4-dione, salze hiervon sowie verfahren zur herstellung - Google Patents
Thiazolidin-2,4-dione, salze hiervon sowie verfahren zur herstellungInfo
- Publication number
- ATE171448T1 ATE171448T1 AT92905305T AT92905305T ATE171448T1 AT E171448 T1 ATE171448 T1 AT E171448T1 AT 92905305 T AT92905305 T AT 92905305T AT 92905305 T AT92905305 T AT 92905305T AT E171448 T1 ATE171448 T1 AT E171448T1
- Authority
- AT
- Austria
- Prior art keywords
- same
- thiazolidine
- dione
- lower alkyl
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5327591 | 1991-02-25 | ||
JP4072496A JP3053490B2 (ja) | 1991-02-25 | 1992-02-21 | チアゾリジン−2,4−ジオン誘導体とその塩及び製造法 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE171448T1 true ATE171448T1 (de) | 1998-10-15 |
Family
ID=26393992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT92905305T ATE171448T1 (de) | 1991-02-25 | 1992-02-24 | Thiazolidin-2,4-dione, salze hiervon sowie verfahren zur herstellung |
Country Status (12)
Country | Link |
---|---|
US (1) | US5342850A (de) |
EP (1) | EP0526658B1 (de) |
JP (1) | JP3053490B2 (de) |
KR (1) | KR960012206B1 (de) |
AT (1) | ATE171448T1 (de) |
AU (1) | AU645886B2 (de) |
CA (1) | CA2081113C (de) |
DE (1) | DE69227080T2 (de) |
DK (1) | DK0526658T3 (de) |
ES (1) | ES2122991T3 (de) |
HU (1) | HU217116B (de) |
WO (1) | WO1992014719A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL113084A (en) * | 1994-03-23 | 1999-01-26 | Sankyo Co | Derivatives of thiazolidine and oxazolidine, processes for their preparation and pharmaceutical preparations containing them |
FR2733685B1 (fr) * | 1995-05-05 | 1997-05-30 | Adir | Utilisation des derives du benzopyrane pour l'obtention de compositions pharmaceutiques destinees au traitement des pathologies liees a l'echangeur c1-/hc03-, na+ independant |
JP3906935B2 (ja) * | 1995-12-18 | 2007-04-18 | 杏林製薬株式会社 | N−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法 |
US6008237A (en) | 1997-12-19 | 1999-12-28 | Merck & Co., Inc. | Arylthiazolidinedione derivatives |
JP3373198B2 (ja) * | 1997-12-19 | 2003-02-04 | メルク エンド カムパニー インコーポレーテッド | アリールチアゾリジンジオン誘導体 |
US6756360B1 (en) * | 1998-12-24 | 2004-06-29 | Metabasis Therapeutics, Inc. | Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes |
WO2000078312A1 (en) * | 1999-06-18 | 2000-12-28 | Merck & Co., Inc. | Arylthiazolidinedione and aryloxazolidinedione derivatives |
EP1194147B1 (de) | 1999-06-18 | 2007-01-10 | Merck & Co., Inc. | Arylthiazolidindion- und aryloxazolidinderivate |
US6965033B2 (en) * | 1999-12-22 | 2005-11-15 | Metabasis Therapeutics, Inc. | Bisamidate phosphonate prodrugs |
US6818776B2 (en) * | 2000-02-01 | 2004-11-16 | Kyorin Pharmaceutical Co., Ltd. | Alkali metal salt of thiazolidine-2,4-dione derivative |
WO2001081327A1 (fr) | 2000-04-25 | 2001-11-01 | Kyorin Pharmaceutical Co., Ltd. | Nouveau cristal stable de derive thiazolidinedione et son procede de production |
US7563774B2 (en) * | 2000-06-29 | 2009-07-21 | Metabasis Therapeutics, Inc. | Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes |
ITRM20020016A1 (it) * | 2002-01-15 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Derivati di acidi fenil(alchil)carbossilici e derivati fenilalchileterociclici dionici, loro uso come medicamenti ad attivita' ipoglicemizza |
WO2006023515A2 (en) * | 2004-08-18 | 2006-03-02 | Metabasis Therapeutics, Inc. | Novel thiazole inhibitors of fructose 1,6-bisphosphatase |
US8686048B2 (en) * | 2010-05-06 | 2014-04-01 | Rhizen Pharmaceuticals Sa | Immunomodulator and anti-inflammatory compounds |
KR102384153B1 (ko) | 2018-01-09 | 2022-04-06 | 주식회사 엘지에너지솔루션 | 이형지 커버를 포함하는 전지팩 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5522636A (en) * | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
JPS5728073A (en) * | 1980-07-29 | 1982-02-15 | Takeda Chem Ind Ltd | Inhibitor for aldose reducing enzyme |
DE3479419D1 (en) * | 1983-01-17 | 1989-09-21 | Pfizer | Aldose reductase inhibiting 5-(2-alkoxyphenyl)thiazolidinediones |
ATE186724T1 (de) * | 1987-09-04 | 1999-12-15 | Beecham Group Plc | Substituierte thiazolidindionderivate |
-
1992
- 1992-02-21 JP JP4072496A patent/JP3053490B2/ja not_active Expired - Fee Related
- 1992-02-24 EP EP92905305A patent/EP0526658B1/de not_active Expired - Lifetime
- 1992-02-24 CA CA002081113A patent/CA2081113C/en not_active Expired - Fee Related
- 1992-02-24 US US07/934,519 patent/US5342850A/en not_active Expired - Fee Related
- 1992-02-24 WO PCT/JP1992/000189 patent/WO1992014719A1/ja active IP Right Grant
- 1992-02-24 HU HU9203284A patent/HU217116B/hu not_active IP Right Cessation
- 1992-02-24 DE DE69227080T patent/DE69227080T2/de not_active Expired - Fee Related
- 1992-02-24 ES ES92905305T patent/ES2122991T3/es not_active Expired - Lifetime
- 1992-02-24 DK DK92905305T patent/DK0526658T3/da active
- 1992-02-24 AT AT92905305T patent/ATE171448T1/de not_active IP Right Cessation
- 1992-02-24 KR KR1019920702622A patent/KR960012206B1/ko not_active IP Right Cessation
- 1992-02-24 AU AU12059/92A patent/AU645886B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
US5342850A (en) | 1994-08-30 |
HUT66972A (en) | 1995-01-30 |
DE69227080T2 (de) | 1999-05-20 |
AU1205992A (en) | 1992-09-15 |
CA2081113A1 (en) | 1992-08-26 |
JPH0592960A (ja) | 1993-04-16 |
HU217116B (hu) | 1999-11-29 |
KR960012206B1 (ko) | 1996-09-16 |
HU9203284D0 (en) | 1992-12-28 |
DE69227080D1 (de) | 1998-10-29 |
EP0526658B1 (de) | 1998-09-23 |
CA2081113C (en) | 2001-03-06 |
WO1992014719A1 (en) | 1992-09-03 |
EP0526658A1 (de) | 1993-02-10 |
KR937000469A (ko) | 1993-03-15 |
DK0526658T3 (da) | 1999-06-14 |
AU645886B2 (en) | 1994-01-27 |
JP3053490B2 (ja) | 2000-06-19 |
ES2122991T3 (es) | 1999-01-01 |
EP0526658A4 (en) | 1993-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE171448T1 (de) | Thiazolidin-2,4-dione, salze hiervon sowie verfahren zur herstellung | |
DE69006984D1 (de) | Thiazolidinedionederivate. | |
FI95469C (fi) | Analogiamenetelmä uusien hypoglykeemisten oksatsolidiinidionien valmistamiseksi | |
KR860009010A (ko) | 티아졸리딘디온의 제조방법 | |
IE44707L (en) | Proline derivatives | |
DK444685A (da) | Tiazolidindionderivater, farmaceutiske praeparater indeholdende dem ogfremgangsmaader til fremstilling deraf | |
DK0615549T3 (da) | Fremgangsmåde til fremstilling af farmaceutisk aktive thiazolidin- eller oxazolidinforbindelser med en gærreduktase | |
KR880002829A (ko) | 디하이드로피리딘 항알러지제 및 소염제 | |
EP1055683A4 (de) | Neuartiges acetamid-derivat und verwendung desselben | |
DE3864707D1 (de) | Benzoxazin-derivate und verfahren zu ihrer herstellung. | |
ATE171450T1 (de) | Thiazolidin-2,4-dion-derivate, salze hiervon sowie verfahren zur herstellung | |
DE69427978T2 (de) | Zwischenprodukt zur verwendung in der synthese und verfahren zur herstellung eines aminopiperazinderivates | |
DE69714076T2 (de) | Herstellung von thiazolen | |
ATE67194T1 (de) | Thiadiazolylacetamid-derivate, verfahren zu ihrer herstellung und ihre verwendung. | |
JPS6438090A (en) | Thiazolidine compound | |
HUT49845A (en) | Process for producing optically active n-substituted alanine derivatives with herbicidal effect |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |